BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

826 related articles for article (PubMed ID: 31703725)

  • 21. Integrated mRNA-miRNA transcriptome profiling of blood immune responses potentially related to pulmonary fibrosis in forest musk deer.
    Qi WH; Hu LF; Gu YJ; Zhang XY; Jiang XM; Li WJ; Qi JS; Xiao GS; Jie H
    Front Immunol; 2024; 15():1404108. PubMed ID: 38873601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening the molecular targets of ovarian cancer based on bioinformatics analysis.
    Du L; Qian X; Dai C; Wang L; Huang D; Wang S; Shen X
    Tumori; 2015; 101(4):384-9. PubMed ID: 25953442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
    Lu M; Kong X; Wang H; Huang G; Ye C; He Z
    Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioinformatic analysis of key pathways and genes shared between endometriosis and ovarian cancer.
    Ni L; Chen Y; Yang J; Chen C
    Arch Gynecol Obstet; 2022 May; 305(5):1329-1342. PubMed ID: 34727222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TTK (threonine tyrosine kinase) regulates the malignant behaviors of cancer cells and is regulated by microRNA-582-5p in ovarian cancer.
    Lu N; Ren L
    Bioengineered; 2021 Dec; 12(1):5759-5768. PubMed ID: 34516342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of microarray-identified genes and microRNAs associated with drug resistance in ovarian cancer.
    Zou J; Yin F; Wang Q; Zhang W; Li L
    Int J Clin Exp Pathol; 2015; 8(6):6847-58. PubMed ID: 26261572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Underlying Molecular Mechanism and Construction of a miRNA-Gene Network in Idiopathic Pulmonary Fibrosis by Bioinformatics.
    Zheng S; Zhang Y; Hou Y; Li H; He J; Zhao H; Sun X; Liu Y
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of enhancer of zeste homolog 2 in cisplatin-resistance in ovarian cancer cells by interacting with several genes.
    Wang H; Yu Y; Chen C; Wang Q; Huang T; Hong F; Zhu L
    Mol Med Rep; 2015 Aug; 12(2):2503-10. PubMed ID: 25955318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioinformatic analysis reveals MIR502 as a potential tumour suppressor in ovarian cancer.
    Li Y; Wang Q; Ning N; Tang F; Wang Y
    J Ovarian Res; 2020 Jul; 13(1):77. PubMed ID: 32660514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of key miRNAs and mRNAs related to coronary artery disease by meta-analysis.
    Liu L; Zhang J; Wu M; Xu H
    BMC Cardiovasc Disord; 2021 Sep; 21(1):443. PubMed ID: 34530741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unveiling Key Biomarkers and Therapeutic Drugs in Polycystic Ovary Syndrome (PCOS) Through Pathway Enrichment Analysis and Hub Gene-miRNA Networks.
    Heidarzadehpilehrood R; Pirhoushiaran M; Binti Osman M; Ling KH; Abdul Hamid H
    Iran J Pharm Res; 2023; 22(1):e139985. PubMed ID: 38444712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Value of miR-101-3p and Biological Analysis of its Prospective Targets in Breast Cancer: A Study Based on The Cancer Genome Atlas (TCGA) and Bioinformatics.
    Li CY; Xiong DD; Huang CQ; He RQ; Liang HW; Pan DH; Wang HL; Wang YW; Zhu HW; Chen G
    Med Sci Monit; 2017 Apr; 23():1857-1871. PubMed ID: 28416776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening and identification of key biomarkers associated with amyotrophic lateral sclerosis and depression using bioinformatics.
    Wang Z; Yang H; Han Y; Teng J; Kong X; Qi X
    Medicine (Baltimore); 2023 Nov; 102(47):e36265. PubMed ID: 38013317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High Expression of miR-532-5p, a Tumor Suppressor, Leads to Better Prognosis in Ovarian Cancer Both In Vivo and In Vitro.
    Wang F; Chang JT; Kao CJ; Huang RS
    Mol Cancer Ther; 2016 May; 15(5):1123-31. PubMed ID: 26873729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of potential therapeutic target genes, key miRNAs and mechanisms in oral lichen planus by bioinformatics analysis.
    Gong C; Sun S; Liu B; Wang J; Chen X
    Arch Oral Biol; 2017 Jun; 78():122-128. PubMed ID: 28237528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of biomarkers of intrahepatic cholangiocarcinoma via integrated analysis of mRNA and miRNA microarray data.
    Chen Y; Liu D; Liu P; Chen Y; Yu H; Zhang Q
    Mol Med Rep; 2017 Mar; 15(3):1051-1056. PubMed ID: 28098904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated miRNA-mRNA analysis of Epstein-Barr virus-positive nasopharyngeal carcinoma.
    Zhu LH; Miao XT; Wang NY
    Genet Mol Res; 2015 Jun; 14(2):6028-36. PubMed ID: 26125802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The biomarkers associated with epithelial-mesenchymal transition in human keloids.
    Qiu ZK; Yang E; Yu NZ; Zhang MZ; Zhang WC; Si LB; Wang XJ
    Burns; 2024 Mar; 50(2):474-487. PubMed ID: 37980270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-efficient Screening Method for Identification of Key Genes in Breast Cancer Through Microarray and Bioinformatics.
    Liu Z; Liang G; Tan L; Su AN; Jiang W; Gong C
    Anticancer Res; 2017 Aug; 37(8):4329-4335. PubMed ID: 28739725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of potential candidate genes for hypertensive nephropathy based on gene expression profile.
    Chen Z; Wu H; Wang G; Feng Y
    BMC Nephrol; 2016 Oct; 17(1):149. PubMed ID: 27756246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.